Identification of a rhodium(iii) complex as a Wee1 inhibitor against TP53-mutated triple-negative breast cancer cells

The rhodium(iii) complex 1 was identified as a potent Wee1 inhibitor in vitro and in cellulo. It decreased Wee1 activity and unscheduled mitotic entry, and induced cell damage and death in TP53-mutated triple-negative breast cancer cells. 1 represents a promising scaffold for further development of more potent metal-based Wee1 antagonists.

Medienart:

E-Artikel

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Zur Gesamtaufnahme - volume:54

Enthalten in:

Chemical communications (Cambridge, England) - 54(2018), 20 vom: 06. März, Seite 2463-2466

Sprache:

Englisch

Beteiligte Personen:

Yang, Guan-Jun [VerfasserIn]
Zhong, Hai-Jing [VerfasserIn]
Ko, Chung-Nga [VerfasserIn]
Wong, Suk-Yu [VerfasserIn]
Vellaisamy, Kasipandi [VerfasserIn]
Ye, Min [VerfasserIn]
Ma, Dik-Lung [VerfasserIn]
Leung, Chung-Hang [VerfasserIn]

Links:

Volltext

Themen:

Cell Cycle Proteins
Coordination Complexes
DMK383DSAC
EC 2.7.10.1
EC 2.7.10.2
Journal Article
Nuclear Proteins
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Rhodium
TP53 protein, human
Tumor Suppressor Protein p53
WEE1 protein, human

Anmerkungen:

Date Completed 11.04.2018

Date Revised 31.03.2022

published: Print

Citation Status MEDLINE

doi:

10.1039/c7cc09384e

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM280285507